logo

For the Inventor, By the Inventor

Dabrowka, Poland

Agnieszka Fiszer

This inventor holds 2 USPTO granted patents. Top assignee: Institute of Bioorganic Chemistry. Active years: 2018-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Agnieszka Fiszer. Retrieved from https://idiyas.com/inventor/agnieszka-fiszer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal2 out of 8 
 
Institute of Bioorganic Chemistry
 patents

Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents
1. 10329566 - Nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interference in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats (2019-06-25),
2. 9970004 - Nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interferencde in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats (2018-05-15),

Title: Agnieszka Fiszer: Innovator in RNA Interference Technology

Introduction

Agnieszka Fiszer is a prominent inventor based in Dabrowka, Poland, known for her contributions to the field of molecular biology and genetic therapy. With two patents to her name, her work is focused on innovative solutions for hereditary neurological diseases. Fiszer's research has the potential to significantly advance therapeutic approaches for conditions that arise from genetic disorders.

Latest Patents

Agnieszka Fiszer's latest patents include inventions related to a nucleic acid molecule, expression cassette, expression vector, and eukaryotic host cell designed to induce RNA interference. Specifically, her innovations address the use of these technologies in the therapy of diseases induced by the expansion of trinucleotide CAG repeats. The subjects of her inventions focus on a new concept for treating hereditary human neurological diseases through RNA interference technology, which shows promise in mitigating the effects of genetic mutations.

Career Highlights

Fiszer is affiliated with the Institute of Bioorganic Chemistry in Poland, where she dedicates her research to exploring new therapeutic methodologies. Her groundbreaking work on RNA interference positions her as a key figure in the biological sciences community, contributing valuable insights and advancements in genetic research.

Collaborations

Throughout her career, Agnieszka Fiszer has worked alongside notable colleagues, including Wlodzimierz Krzyzosiak and Marta Olejniczak. Their collaborations foster an environment of innovation, allowing for the exchange of ideas and expertise that further advance the field of molecular genetics.

Conclusion

With her inventive spirit and commitment to addressing genetic disorders, Agnieszka Fiszer stands out as a significant contributor in the realm of RNA interference technology. As she continues her research, her patents will likely pave the way for new treatments, improving the quality of life for individuals affected by hereditary diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…